Camp4 Therapeutics (CAMP) Share-based Compensation (2023 - 2026)
Camp4 Therapeutics (CAMP) posted Share-based Compensation of $1.5 million for Q1 2026, up 27.89% sequentially from $1.2 million in Q4 2025, and up 70.96% YoY from $861000.0 in Q1 2025.
Camp4 Therapeutics (CAMP) Share-based Compensation (2023 - 2026) Analysis & Trends
Camp4 Therapeutics has reported Share-based Compensation for 4 years, with the latest figure at $1.5 million in Q1 2026.
- Quarterly Share-based Compensation rose 70.96% year-over-year to $1.5 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $4.6 million (up 39.67% YoY) and the FY2025 annual result came in at $4.0 million, down 0.84% from the prior year.
- Share-based Compensation rose to $1.5 million in Q1 2026 per CAMP's latest filing, from $1.2 million in the prior quarter.
- Over five years, Share-based Compensation peaked at $7.2 million in Q3 2024 and troughed at -$874000.0 in Q4 2023.
- A 4-year average of $1.4 million and a median of $861000.0 in 2025 frame the typical range for Share-based Compensation.
- The sharpest annual moves came in 2024 and 2025: Share-based Compensation soared 897.23% in 2024, then slumped 86.33% in 2025.
- Over 4 years, Share-based Compensation stood at -$874000.0 in 2023, then surged by 191.19% to $797000.0 in 2024, then surged by 44.42% to $1.2 million in 2025, then rose by 27.89% to $1.5 million in 2026.
- According to Business Quant data, Share-based Compensation over the past three periods registered $1.5 million, $1.2 million, and $984000.0 for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Share-based Compensation (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 108.10 Mn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 243.00 Mn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | - |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | 277.20 Mn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 137.41 Mn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 590,899.88 |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 86.63 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 41.25 Mn |
| 10 | Camp4 Therapeutics | 282.48 Mn | 282.48 Mn | - | 1.93 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 1.93 Mn |
| Jun 30, 2026 | 1.93 Mn |
| Mar 31, 2026 | 1.47 Mn |
| Mar 31, 2026 | 1.47 Mn |
| Dec 31, 2025 | 1.15 Mn |
| Dec 31, 2025 | 1.15 Mn |
| Sep 30, 2025 | 984,000.00 |
| Sep 30, 2025 | 984,000.00 |
| Jun 30, 2025 | 1.00 Mn |
| Jun 30, 2025 | 1.00 Mn |
| Mar 31, 2025 | 861,000.00 |
| Mar 31, 2025 | 861,000.00 |
| Dec 31, 2024 | 797,000.00 |
| Dec 31, 2024 | 797,000.00 |
| Sep 30, 2024 | 7.20 Mn |
| Sep 30, 2024 | 7.20 Mn |
| Jun 30, 2024 | 786,000.00 |
| Jun 30, 2024 | 786,000.00 |
| Mar 31, 2024 | 856,000.00 |
| Mar 31, 2024 | 856,000.00 |